• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种组织异质性的统计测量方法及其在三维正电子发射断层扫描(PET)肉瘤数据中的应用。

A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data.

作者信息

O'Sullivan Finbarr, Roy Supratik, Eary Janet

机构信息

The Statistical Laboratory, Department of Statistics, University College, Cork, Ireland.

出版信息

Biostatistics. 2003 Jul;4(3):433-48. doi: 10.1093/biostatistics/4.3.433.

DOI:10.1093/biostatistics/4.3.433
PMID:12925510
Abstract

In vivo measurement of local tissue characteristics by modern bioimaging techniques such as positron emission tomography (PET) provides the opportunity to analyze quantitatively the role that tissue heterogeneity may play in understanding biological function. This paper develops a statistical measure of the heterogeneity of a tissue characteristic that is based on the deviation of the distribution of the tissue characteristic from a unimodal elliptically contoured spatial pattern. An efficient algorithm is developed for computation of the measure based on volumetric region of interest data. The technique is illustrated by application to data from PET imaging studies of fluorodeoxyglucose utilization in human sarcomas. A set of 74 sarcoma patients (with five-year follow-up survival information) were evaluated for heterogeneity as well as a number of other potential prognostic indicators of survival. A Cox proportional hazards analysis of these data shows that the degree of heterogeneity of the sarcoma is the major risk factor associated with patient death. Some theory is developed to analyze the asymptotic statistical behavior of the heterogeneity estimator. In the context of data arising from Poisson deconvolution (PET being the prime example), the heterogeneity estimator, which is a non-linear functional of the PET image data, is consistent and converges at a rate that is parametric in the injected dose.

摘要

通过正电子发射断层扫描(PET)等现代生物成像技术对局部组织特征进行体内测量,为定量分析组织异质性在理解生物学功能中可能发挥的作用提供了机会。本文基于组织特征分布与单峰椭圆轮廓空间模式的偏差,开发了一种组织特征异质性的统计量度。基于感兴趣体积区域数据,开发了一种计算该量度的高效算法。通过将该技术应用于人类肉瘤中氟脱氧葡萄糖利用的PET成像研究数据进行了说明。对一组74例肉瘤患者(有五年随访生存信息)进行了异质性以及其他一些潜在生存预后指标的评估。对这些数据进行的Cox比例风险分析表明,肉瘤的异质性程度是与患者死亡相关的主要风险因素。还发展了一些理论来分析异质性估计量的渐近统计行为。在泊松反卷积产生的数据背景下(PET是主要例子),作为PET图像数据的非线性泛函的异质性估计量是一致的,并且以与注射剂量相关的参数速率收敛。

相似文献

1
A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data.一种组织异质性的统计测量方法及其在三维正电子发射断层扫描(PET)肉瘤数据中的应用。
Biostatistics. 2003 Jul;4(3):433-48. doi: 10.1093/biostatistics/4.3.433.
2
Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET.将肿瘤形状纳入用FDG-PET成像的人类肉瘤空间异质性评估中。
Biostatistics. 2005 Apr;6(2):293-301. doi: 10.1093/biostatistics/kxi010.
3
Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.肉瘤中18F-FDG摄取的空间异质性作为患者预后的预测指标。
J Nucl Med. 2008 Dec;49(12):1973-9. doi: 10.2967/jnumed.108.053397. Epub 2008 Nov 7.
4
A statistical modeling approach to the analysis of spatial patterns of FDG-PET uptake in human sarcoma.一种用于分析人类肉瘤中 FDG-PET 摄取的空间模式的统计建模方法。
IEEE Trans Med Imaging. 2011 Dec;30(12):2059-71. doi: 10.1109/TMI.2011.2160984. Epub 2011 Jun 30.
5
Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas.氟代脱氧葡萄糖正电子发射断层扫描:成人软组织肉瘤的基本原理与成像
J Bone Joint Surg Am. 2004;86-A Suppl 2:98-104.
6
PET-MR image fusion in soft tissue sarcoma: accuracy, reliability and practicality of interactive point-based and automated mutual information techniques.软组织肉瘤的PET-MR图像融合:基于交互式点和自动互信息技术的准确性、可靠性及实用性
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):54-62. doi: 10.1007/s00259-002-0994-z. Epub 2002 Oct 11.
7
Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.定量[F-18]氟脱氧葡萄糖正电子发射断层扫描在肉瘤预处理和分级中的应用
Clin Cancer Res. 1998 May;4(5):1215-20.
8
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.通过正电子发射断层显像(PET)测量的肉瘤肿瘤氟代脱氧葡萄糖(FDG)摄取与患者预后:一项回顾性分析。
Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1149-54. doi: 10.1007/s00259-002-0859-5. Epub 2002 Jun 19.
9
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.(F-18)氟脱氧葡萄糖正电子发射断层扫描作为骨与软组织肉瘤病理分级及其他预后变量的预测指标
Clin Cancer Res. 2000 Apr;6(4):1279-87.
10
Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.氟-18-脱氧葡萄糖正电子发射断层扫描在检测局部复发性和远处转移性肉瘤中的作用。
Clin Nucl Med. 2003 Oct;28(10):815-20. doi: 10.1097/01.rlu.0000089523.00672.2b.

引用本文的文献

1
PET Imaging of Metabolism, Perfusion, and Hypoxia: FDG and Beyond.正电子发射断层成像术的代谢、灌注和缺氧显像:FDG 及其他
Cancer J. 2024;30(3):159-169. doi: 10.1097/PPO.0000000000000716.
2
"Fuzzy" radiomics: the way forward for nuclear medicine imaging applications?“模糊”放射组学:核医学成像应用的未来之路?
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1558-1559. doi: 10.1007/s00259-023-06201-8.
3
A phylogenetic approach to inferring the order in which mutations arise during cancer progression.一种推断癌症进展过程中突变发生顺序的系统发育方法。
PLoS Comput Biol. 2022 Dec 2;18(12):e1010560. doi: 10.1371/journal.pcbi.1010560. eCollection 2022 Dec.
4
Joint EANM/SNMMI guideline on radiomics in nuclear medicine : Jointly supported by the EANM Physics Committee and the SNMMI Physics, Instrumentation and Data Sciences Council.核医学影像组学 EANM/SNMMI 指南:由 EANM 物理委员会和 SNMMI 物理、仪器和数据科学委员会共同支持。
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):352-375. doi: 10.1007/s00259-022-06001-6. Epub 2022 Nov 3.
5
PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology.正电子发射断层扫描(PET)分子影像学:对当前临床肿瘤学中诊断、治疗评估和预后的实践现状和新兴观点的全面综述。
Int J Mol Sci. 2021 Apr 16;22(8):4159. doi: 10.3390/ijms22084159.
6
AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomics.基于人工智能的混合成像应用:如何为放射组学构建智能且真正多参数的决策模型。
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2673-2699. doi: 10.1007/s00259-019-04414-4. Epub 2019 Jul 11.
7
MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma.MRI影像组学特征与软组织肉瘤的总生存期独立相关。
Adv Radiat Oncol. 2019 Feb 23;4(2):413-421. doi: 10.1016/j.adro.2019.02.003. eCollection 2019 Apr-Jun.
8
Preclinical PET tracers for the evaluation of sarcomas: understanding tumor biology.用于评估肉瘤的临床前PET示踪剂:了解肿瘤生物学
Am J Nucl Med Mol Imaging. 2018 Dec 20;8(6):428-440. eCollection 2018.
9
Heterogeneity in Metastatic Breast Cancer F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?转移性乳腺癌中F-氟雌二醇摄取的异质性:具有临床可操作性,对生物学有启示作用?
J Nucl Med. 2018 Aug;59(8):1210-1211. doi: 10.2967/jnumed.118.214304. Epub 2018 Jun 14.
10
Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma.基于正电子发射断层扫描的肉瘤代谢梯度及其他预后特征评估
J Med Imaging (Bellingham). 2018 Apr;5(2):024502. doi: 10.1117/1.JMI.5.2.024502. Epub 2018 May 24.